DK1179183T3 - Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr - Google Patents

Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr

Info

Publication number
DK1179183T3
DK1179183T3 DK00918600.8T DK00918600T DK1179183T3 DK 1179183 T3 DK1179183 T3 DK 1179183T3 DK 00918600 T DK00918600 T DK 00918600T DK 1179183 T3 DK1179183 T3 DK 1179183T3
Authority
DK
Denmark
Prior art keywords
neoplastic
mammals
identifying pre
conditions
identifying
Prior art date
Application number
DK00918600.8T
Other languages
English (en)
Inventor
Michael Slater
Julian Barden
Original Assignee
Biosceptre Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosceptre Int Ltd filed Critical Biosceptre Int Ltd
Application granted granted Critical
Publication of DK1179183T3 publication Critical patent/DK1179183T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK00918600.8T 1999-04-21 2000-04-26 Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr DK1179183T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPP9911A AUPP991199A0 (en) 1999-04-21 1999-04-21 Methods for diagnosing pre-cancerous and cancerous conditions
PCT/AU2000/000363 WO2001006259A1 (en) 1999-04-21 2000-04-26 A method for identifying pre-neoplastic and/or neoplastic states in mammals

Publications (1)

Publication Number Publication Date
DK1179183T3 true DK1179183T3 (da) 2010-05-25

Family

ID=3814111

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00918600.8T DK1179183T3 (da) 1999-04-21 2000-04-26 Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr

Country Status (14)

Country Link
US (3) US7183064B1 (da)
EP (1) EP1179183B1 (da)
JP (1) JP4633984B2 (da)
KR (1) KR100819395B1 (da)
CN (1) CN100557445C (da)
AT (1) ATE456799T1 (da)
AU (2) AUPP991199A0 (da)
CA (1) CA2371163A1 (da)
DE (1) DE60043775D1 (da)
DK (1) DK1179183T3 (da)
ES (1) ES2340137T3 (da)
NO (1) NO331018B1 (da)
WO (1) WO2001006259A1 (da)
ZA (1) ZA200108616B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
JP4384852B2 (ja) * 2001-01-17 2009-12-16 イントリート ピーティーワイ リミテッド 非機能性ｐ２ｘ７レセプター抗体、癌及びその他の容態の診断及び処置
JP2010505426A (ja) 2006-10-10 2010-02-25 バイオスセプター インターナショナル リミテッド 非機能性ｐ２ｘ７受容体に対する抗体を産生するハイブリドーマ
ATE542139T1 (de) * 2007-09-14 2012-02-15 Biosceptre Int Ltd Purinerge (p2x)-rezeptoren in extrazellulärer körperflüssigkeit
AU2013238152B2 (en) * 2007-09-14 2015-09-24 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
ES2619681T3 (es) 2007-09-14 2017-06-26 Biosceptre (Aust) Pty Ltd Novedosos epítopos P2X7
CN102143978B (zh) 2008-07-04 2015-02-18 生物权威国际有限公司 抗p2x7肽和表位
CN102257003B (zh) * 2008-12-19 2017-04-05 埃博灵克斯股份有限公司 用于产生针对细胞相关抗原如p2x7、cxcr7或cxcr4的免疫球蛋白的基因免疫
EP2467404B1 (en) 2009-08-20 2015-09-30 Biosceptre International Limited Anti p2x7 receptor antibodies and fragments thereof
WO2011075789A1 (en) 2009-12-24 2011-06-30 Biosceptre International Limited Antibodies to non-functional oligomeric p2x7 receptors
EP2613808B1 (en) 2010-09-10 2017-11-08 Biosceptre (Aust) Pty Ltd Companion animal cancer treatments with an anti p2x7 antibody
MX349321B (es) 2011-07-01 2017-07-21 Biosceptre (Aust) Pty Ltd Terapia combinada.
US10654926B2 (en) * 2014-05-02 2020-05-19 Medimmune Limited P2X4 antibodies and uses thereof
US12121539B2 (en) 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
MX2019004410A (es) 2016-10-21 2019-09-26 Biosceptre Uk Ltd Particulas citotoxicas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920765A1 (en) * 1991-03-12 1992-09-23 Scripps Research Inst Cell surface receptors homologous to coagulation factors v¹and viii
JP3084982B2 (ja) * 1992-11-25 2000-09-04 富士電機株式会社 半導体装置
AU2566595A (en) 1994-05-27 1995-12-21 Glaxo Group Limited P-2x receptors (purinoceptor family)
WO1997006256A2 (en) * 1995-08-09 1997-02-20 Institut National De La Sante Et De La Recherche Medicale Isolated nucleic acid molecules useful as leukemia markers and in breast cancer prognosis
JP2001521372A (ja) 1996-04-30 2001-11-06 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ヒトＰ２ｘ４レセプタースプライス−変異体
US6303338B1 (en) * 1996-08-16 2001-10-16 Human Genome Sciences, Inc. Pancreas-derived plasminogen activator inhibitor
JP3885177B2 (ja) 1997-03-26 2007-02-21 大塚製薬株式会社 ヒト遺伝子
US6133434A (en) * 1997-04-28 2000-10-17 Glaxo Group Limited Purinergic receptor
DE19829473C2 (de) * 1998-07-01 2000-08-10 Magnus Von Knebel Doeberitz Ch Verfahren zur frühen Diagnose von Carcinomen
AUPP991199A0 (en) * 1999-04-21 1999-05-13 University Of Sydney, The Methods for diagnosing pre-cancerous and cancerous conditions
AUPR201500A0 (en) * 2000-12-11 2001-01-11 Biosceptre Pty Ltd Methods for identifying pre-neoplastic and neoplastic states in mammals
JP4384852B2 (ja) * 2001-01-17 2009-12-16 イントリート ピーティーワイ リミテッド 非機能性ｐ２ｘ７レセプター抗体、癌及びその他の容態の診断及び処置

Also Published As

Publication number Publication date
NO20015157D0 (no) 2001-10-22
JP4633984B2 (ja) 2011-02-16
CA2371163A1 (en) 2001-01-25
NO331018B1 (no) 2011-09-12
CN1355886A (zh) 2002-06-26
EP1179183A1 (en) 2002-02-13
HK1044190A1 (en) 2002-10-11
EP1179183A4 (en) 2003-01-22
CN100557445C (zh) 2009-11-04
ES2340137T3 (es) 2010-05-31
DE60043775D1 (de) 2010-03-18
ATE456799T1 (de) 2010-02-15
KR100819395B1 (ko) 2008-04-04
NO20015157L (no) 2001-12-21
US20110111431A1 (en) 2011-05-12
US7183064B1 (en) 2007-02-27
US20070248963A1 (en) 2007-10-25
KR20020022651A (ko) 2002-03-27
AU779845B2 (en) 2005-02-17
WO2001006259A1 (en) 2001-01-25
EP1179183B1 (en) 2010-01-27
ZA200108616B (en) 2002-06-13
AU3949000A (en) 2001-02-05
AUPP991199A0 (en) 1999-05-13
JP2003504643A (ja) 2003-02-04

Similar Documents

Publication Publication Date Title
DK1179183T3 (da) Fremgangsmåde til identifikation af præneoplastiske og/eller neoplastiske tilstande hos pattedyr
DK1137798T3 (da) Fremgangsmåde til isolering af stamceller
DE69914119D1 (de) Verbesserungen an, oder bezüglich, Rohrkupplungen
DK1100381T3 (da) Indretning til reparation af arterier
DK1290444T3 (da) Toxicitetstypisering under anvendelse af lever-stamceller
EP1131333A4 (en) INSULATED NUCLEIC ACID MOLECULES ENCODING INDUCIBLE FACTORS DERIVED FROM T-CELL (TIF), ENCODED PROTEINS AND USE THEREOF
DE58903735D1 (de) Verwendung ausgewaehlter esteroele in bohrspuelungen insbesondere zur off-shore-erschliessung von erdoel- bzw. erdgasvorkommen (ii).
NO20065084L (no) Interferon-alfa polypeptider og konjugater
ATE424560T1 (de) Marker für neuromyelitis optica
NO20052363L (no) Interferon-alfa polypeptider og konjugater
EP1352085A4 (en) P2y purinergic receptor expression for identifying preneoplastic and neoplastic states
NO20053357D0 (no) Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse.
BR9703386A (pt) Células aviárias imortalizadas
TR199601037A2 (tr) Suda cözülebilir azo boyarmaddeleri, bunlarin imal edilmesine mahsus usul ve bunlarin kullanilmasi.
ATE309140T1 (de) Behälterbausatz
PT1127133E (pt) Polipeptido que proporciona permeabilidade celular
BR0204865B1 (pt) acoplamento hidrÁulico submarino com vedaÇÕes radiais na sonda.
IT1315777B1 (it) Procedimento per controllare la trapanazione elettrochimica.
IT245621Y1 (it) Raccordo, in particolare raccordo per tubazioni
ATE267206T1 (de) 5-imino-13-deoxy-antracyclin-derivate, ihre verwendung sowie verfahren zu deren herstellung
DE69803969D1 (de) Zelle mit Pseudo-Kapazität, insbesondere für künstliche Netzhaut
ATE293987T1 (de) Methode zur mobilisierung hematopoietischer stammzellen
BR9706481B1 (pt) mÉtodo para detectar alteraÇÕes nas propriedades fÍsicas de fluidos em tubulaÇÕes.
IT1296551B1 (it) Metodo per il controllo elettro-ottico di foglietti, in particolare banconote.
DK1301795T3 (da) Fremgangsmåde til identificering og/eller isolering af stamceller